DEPLOYMENT PLAN FOR THE
WORLDWIDE DISTRIBUTION OF AN INNOVATIVE
ALL NATURAL MOSQUITO PILL
Link to Cover Memorandum from Institute President
This Plan has been developed by M-Powers, LLC and the Institute for Health Research, as a collaborative effort in response to summer of 2016 mosquito-carried disease concerns. Subject to sufficient, timely funding, it is our intent to offer the Pill free of charge to participants in the Brazil 2016 Summer Olympics.
The mosquito defense product (herein, the Mosquito Product or Pill) naturally protects users from insects sucking blood from people and animals. When one gets a mosquito sting the itch and swelling is caused by the insect when injecting its saliva which contains an anticoagulant to allow an easier flow of blood. With this anticoagulant diseases (in case the mosquito is the bearer of any of them) are transmitted.
This dietary supplement contains a proprietary blend of natural herbal and homeopathic ingredients, free of any of the chemicals that are contained in the traditional insect repellents such as diethyltoluamide, also called DEET. It comes in the form of a chewable pill that needs to be ingested 24 hours before expected exposure to the insects. For first time users in the first 7 days 3 pills daily have to be taken. All others take two pills daily with plenty of water which will provide the necessary protection. It supports your body's ability to be unpalatable to these stinging insects which depend on their sense of smell to locate appetizing humans and other mammals. By supporting the body’s homeostasis and normal functioning, it encourages the mosquitoes to look elsewhere for unprotected victims.
The Inventor and His Company
M-foods (not its real name) is a medium-sized company at the south-western edge of the Black Forest region of Germany that was established in 1984. Their specialty is the formulation and manufacture of new products in the field of dietary supplements, dietary food and special products for healthy nutrition. The cooperation with noted scientific institutions and product development has been and is the focus of this company. The company, over many years, acquired an uncommonly extensive knowledge in the sector of alternative medicine and has extensive training in nutritional science. This activity led into the branch of high quality pet food supplements and ultimately into specialized nutritional products for competitive sports and general athletic activities. Due to the steady growth process of the Company and the more than 40 years of experience of the owner and product developer, new divisions have more recently been added to expand their range of products into the international baby food and soft drink industry.
The Company founder has personally developed and formulated in more than 40 years over 3,000 all natural products. Among them are various unique remedies which stand alone in the world in their singularity. These are, as all his products, organically based with no use of any chemicals whatsoever.
His company is certified according to the IOS which is the International Organization for Standardization, an international standard setting body composed of representatives from various national standards organizations. IOS was founded 68 years ago and promotes worldwide proprietary, industrial and commercial standards.
founder, after many years of experimenting, testing and
travelling to exotic places around the globe, has studied a large
technical literature and the ancient art of the sages and shamans using
unconventional and little known plants, roots and barks to ultimately
products that may very well have no equal in the industry. He devised
true to his mantra of not using chemicals in any and all of his
that have a major influence on humans and animals as well. Thus, the
impact of all his products is achieved by the absence of any side
The Story Behind The Product
Tests of the Efficacy of the Mosquito Pill
Informal testing has been extensively conducted in Germany and Australia. In each of these tests the subjects took one pill a day one day before the start of the test. They were all wearing shorts and short sleeves shirts and were continually exposed to mosquitoes in the early evening hours of dusk. A few of the test subjects were bitten by them leaving only superficial sting marks without any itch or swelling.
This means that the mosquitoes probed the outer layer of the skin without inserting their saliva or sucking blood. All the other test subjects showed no bite marks whatsoever. It is noteworthy to mention that half of the group that had not used the pill applied traditional DEET mosquito repellent and still showed some swollen and itching bite marks. In all the tests in Germany there were always 2 persons who did not use the pill or any traditional repellents. Needless to say they were stung numerous times.
About 15 people participated in these tests and counting the superficial stings as actual bites there was still a success rate of more than 9O %. The one test subject in Australia was sitting outside in the evening hours where and when mosquitoes were biting the most. Next to him
his wife who had not taken the mosquito repellent pill. After
she was bitten numerous times she hastily retreated to the house for
whereas her husband was exposed to mosquitoes for an additional 2 hours
not bitten at all. The test subject in Australia tested the pill
Australian summer for a total of 50 - 60 hours of exposure and
has not received any bites.
Partial Disclosure of Proprietary Formula
The following is a list of the ingredients in the Mosquito Pill Formula, without disclosing the proprietary ratios and process. Subject to the Formula Owner’s rights.
Separating Agent Microcrystalline Cellulose
Separating Agent Magnesium stearate
Burnet root powder (Radux pimpinellae)
Vitamin B1 (Thiamine)
Vitamin B2 (riboflavin)
Vitamin B6 (Pyrodoxinhydrochloride)
Vitamin E (D, L-alpha-Tocopherylacetate)
Proprietary homeopathic ingredient
These ingredients have traditional use in herbology and homeopathy regarding insect/human interactions.
Use of Rapid Deployment Funds
& Accounting 100
Royalty Advance to German Inventor 200
M-Powers Costs and Overhead 100
Consulting and Research 050
Initial Inventory 350
Social Media and Advertising 150
Use of Funds is estimated in thousands of dollars.
Rapid Deployment for Public Health Promotion
The initial inventory will be approximately 50,000 units, but production can be rapidly escalated to meet market needs. The manufacturer assures the ability for rapid deployment during the Zika Emergency.
The inventor’s company, is a substantial food producer in Germany and internationally.
With the publicity attendant upon the 2016 Brazil Olympics, and our offer to provide samples to the athletes participating, our social media campaign will permit rapid deployment and consequent benefit to the general public health.
The Company, M-Powers, LLC, seeks to raise one million dollars to enable rapid production and deployment of the Mosquito Pill for wide-scale delivery this summer, 2016. Working in collaboration with the NGO Institute for Health Research, we seek those funds through government or private grants, or other forms of “angel” financing. Our Crowd Funding site is through the Institute and may be found at: https://igg.me/at/GWDrnr8rBJo
We expect to apply our experience in the dietary supplement industry and social media marketing to the rapid deployment of the Mosquito Pill, subject to adequate and timely public and private funding.
declared Zika epidemic has alerted
the public to the dangers of mosquito bites. Our product is ready for
at a time when this health crisis has reached critical proportions. The
availability of funds will allow us to rise to the occasion and make
product available when it is needed most urgently. There has hardly
such an ideal symbiosis between an anxious public and the availability
product that brings salvation at the right time.
We are seeking full funding through Angel Financing including grants and Crowd Funding. The immediate Crowd Funding Goal is $50,000 to enable to M-Powers to obtain the product from the Company for use with the Olympic athletes, as permitted by the Olympic or Brazilian authorities.
Institute for Health Research
This is a draft deployment plan. It does not imply an offering of securities.
This memorandum contains forward-looking statements that are based on management's expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results may vary.